Donovanosis physical examination

Revision as of 18:48, 2 March 2016 by Nate Michalak (talk | contribs)
Jump to navigation Jump to search

Donovanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Donovanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Donovanosis physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Donovanosis physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Donovanosis physical examination

CDC on Donovanosis physical examination

Donovanosis physical examination in the news

Blogs on Donovanosis physical examination

Directions to Hospitals Treating Donovanosis

Risk calculators and risk factors for Donovanosis physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]; Kiran Singh, M.D. [3]; Nate Michalak, B.A.

Overview

Clinically, the disease is commonly characterized as painless, progressive ulcerative lesions without regional lymphadenopathy.

Physical Examination

Clinically, the disease is commonly characterized as painless, progressive ulcerative lesions without regional lymphadenopathy. The lesions are highly vascular (i.e., beefy red appearance) and bleed easily on contact. However, the clinical presentation also can include hypertrophic, necrotic, or sclerotic variants.

Gallery

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 "Dermatology Atlas".
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 "Public Health Image Library (PHIL)".


Template:WikiDoc Sources